$117 Million In Damages Sends Message That Johnson’s Baby Powder Isn’t As Pure As You think.

By Daniel R. Lapinski |   Apr. 24, 2018

On April 5th a New Jersey state court jury found Johnson & Johnson (J&J) and its talc supplier, Imerys Talc America, liable for claims that a man developed mesothelioma after using defendants’ talcum powder products over several decades.  The $37 million compensatory damage award was followed on Wednesday, April 11th with an $80 million punitive damage award after finding that defendants acted with reckless indifference in selling talcum powder products containing asbestos.  Plaintiffs asserted during the trial that defendants knew the products contained asbestos, but hid the fact from consumers and regulators by using tests it knew would not detect the contaminant.

Read More

Topics : defective drug claims, talc based powder exposure, Johnson & Johnson, ovarian cancer linked to talc, defective drug, talc exposure, manufacturers talc-based powder, Imerys Talc, powder, warning, beauty products, baby powder, talc, defective design, asbestos | 0 Comments Read More

Bard Found Liable In First IVC Filter Bellwether Trial

By Daniel R. Lapinski |   Apr. 5, 2018

An Arizona jury has found defendant C.R. Bard, Inc. liable for negligent failure to warn about claims related to its IVC filter.  The plaintiff, Sherri Booker, was awarded $2 million in compensatory damages and $2 million in punitive damages following the trial in Arizona federal court.

Read More

Topics : ivc filter, cr bard inc, ivc filter mdl, ivc filter bellwether trial, small spider-like devices, sherri booker plaintiff, ivc filters | 0 Comments Read More

J&J Looks at Third Strike In DePuy Pinnacle Hip Implant Litigation

By Daniel R. Lapinski |   Nov. 27, 2017

For the third time in a row, Johnson & Johnson (J&J) and its subsidiary, DePuy, have been hit with a 9-figure verdict in a bellwether trial involving DePuy’s Pinnacle line of metal-on-metal hip implants.  On November 16, 2017, after a two-month trial, a unanimous jury found the implant manufacturers liable for design defect, negligent design and inadequate warning, among other things.  The $247 million award to the six individual plaintiffs included $168 million in punitive damages against these companies for wanton, reckless and malicious conduct.

Read More

Topics : Johnson & Johnson, depuy pinnacle, hip implant litigation, depuy, metal on metal hip implants, hip implants, bellwether trial, depuy pinnacle hip implant, depuy pinnacle litigation | 0 Comments Read More

Daniel R. Lapinski Appointed Member of Plaintiffs’ Steering Committee In Proton-Pump Inhibitor Products Liability Litigation

By Daniel R. Lapinski |   Aug. 28, 2017

On August 23, 2017, Daniel R. Lapinski was appointed as a member of the Plaintiffs' Steering Committee in In re: Proton-Pump Inhibitor Products Liability Litigation, MDL No. 2789.  The coordinated litigation is currently centralized before the Honorable Claire C. Cecchi, United States District Judge, in the United States District Court for the District of New Jersey.  Proton-Pump Inhibitors (PPIs) are a class of medications commonly used to treat gastroesophageal reflux (GERD), dyspepsia , gastric ulcers and acid peptic disease. The more popular forms of PPIs include Prilosec, Prevacid, Nexium and AcipHex.  Complaints against the manufacturers of these popular medications allege that the drugs are linked to an increased risk of chronic kidney disease and acute kidney injury.

Read More

Topics : Litigation, New Jersey Litigation, plaintiffs steering committee, proton pump inhibitor products liability, products liability litigation | 0 Comments Read More

    All Blog Posts

    Subscribe to Email Updates

    Featured Blogger

    Daniel R. Lapinski

    Daniel R. Lapinski

    Click Here to Read My Latest Blog Post